KalVista Pharmaceuticals, Inc. (KALV) Covered Calls

You can sell covered calls on KalVista Pharmaceuticals, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for KALV (prices last updated Mon 11:30 AM ET):

KalVista Pharmaceuticals, Inc. (KALV) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
9.32 -0.17 9.32 9.36 240K - 0.4
Covered Calls For KalVista Pharmaceuticals, Inc. (KALV)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Dec 20 10 0.00 9.36 0.0% 0.0%
Jan 17 10 0.40 8.96 4.5% 26.9%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral plasma kallikrein inhibitors. Its products include KVD001, a plasma kallikrein inhibitor that completed a Phase II clinical trial for the treatment of DME; KVD900, which is in Phase II clinical trial for treating HAE attacks; and KVD824, an oral plasma kallikrein inhibitor that completed a Phase I clinical trial for treating DME or HAE. The company is headquartered in Cambridge, Massachusetts.